CONCERN #1: STUBBORN, CHRONIC INFLAMMATION THAT WON'T SUBSIDE Description: This isn't the acute inflammation you get from a sprained ankle
For beginners, the honest summary is that BPC-157 and TB-500 are two well-studied research peptides with complementary mechanisms and a popular nickname, not a clinically validated combination
On July 23 and 24, the FDA's Pharmacy Compounding Advisory Committee (PCAC) met to consider whether certain peptides, including TB-500, should be added to the 503A Bulks List, which is a list of drug substances that the FDA has approved for compounding
The page lists two purity numbers: 99% in the specs and 98.5% on the badge
They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition